Related references
Note: Only part of the references are listed.Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
B. Greenberg et al.
GENE THERAPY (2016)
A Raf kinase inhibitor demonstrates antiviral activities both in vitro and in vivo against different genotypes of virulent Newcastle disease virus
Renfu Yin et al.
ANTIVIRAL RESEARCH (2016)
Chronic heart failure: Ca2+, catabolism, and catastrophic cell death
Geoffrey W. Cho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
β-adrenergic receptor signalling and its functional consequences in the diseased heart
Aref Najafi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift
Hitoshi Uchinoumi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Role of protein phosphatase inhibitor-1 in cardiac beta adrenergic pathway
Silvio Weber et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Calcium Ions in Inherited Cardiomyopathies
Spyridon Deftereos et al.
MEDICINAL CHEMISTRY (2016)
Analyzing ERK 1/2 signalling and targets
Alexandra Brietz et al.
MOLECULAR BIOSYSTEMS (2016)
Pharmacology of heart failure: From basic science to novel therapies
Achim Lother et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure A Randomized Clinical Trial
H. Kirk Hammond et al.
JAMA CARDIOLOGY (2016)
Targets for therapy in sarcomeric cardiomyopathies
Jil C. Tardiff et al.
CARDIOVASCULAR RESEARCH (2015)
Gene therapy for heart failure
Barry Greenberg
JOURNAL OF CARDIOLOGY (2015)
S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction
Julia Ritterhoff et al.
MOLECULAR THERAPY (2015)
Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy
Evelyn Schmid et al.
NATURE MEDICINE (2015)
Cardiac Sarcoplasmic Reticulum Calcium Leak: Basis and Roles in Cardiac Dysfunction
Donald M. Bers
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Enhanced Expression of β3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase
Catharina Belge et al.
CIRCULATION (2014)
Cardiac Calcium Handling on Trial Targeting the Failing Cardiomyocyte Signalosome
Sven T. Pleger et al.
CIRCULATION RESEARCH (2014)
Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend
Kobra Haghighi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Adrenergic signaling in heart failure: a balance of toxic and protective effects
Anthony J. Baker
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Heart failure-specific changes in protein kinase signalling
Kristina Lorenz et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Design of a Phase 2b Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Advanced Heart Failure The CUPID 2 Trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease Phase 2b)
Barry Greenberg et al.
JACC-HEART FAILURE (2014)
Spatial control of the βAR system in heart failure: the transverse tubule and beyond
Julia Gorelik et al.
CARDIOVASCULAR RESEARCH (2013)
Epac2 Mediates Cardiac β1-Adrenergic-Dependent Sarcoplasmic Reticulum Ca2+ Leak and Arrhythmia
Laetitia Pereira et al.
CIRCULATION (2013)
Cardiotoxic and Cardioprotective Features of Chronic β-Adrenergic Signaling
Xiaoying Zhang et al.
CIRCULATION RESEARCH (2013)
Inhibition of G-protein-coupled Receptor Kinase 2 (GRK2) Triggers the Growth-promoting Mitogen-activated Protein Kinase (MAPK) Pathway
Xuebin Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Calcium cycling proteins and heart failure: mechanisms and therapeutics
Andrew R. Marks
JOURNAL OF CLINICAL INVESTIGATION (2013)
Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice
Giovanni Fajardo et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy
Catharina Ruppert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Beta3-Adrenoreceptors in Cardiovasular Diseases: New Roles for an Old Receptor
Jean-Luc Balligand
CURRENT DRUG DELIVERY (2013)
β-Adrenergic receptor subtype signaling in heart: From bench to bedside
Anthony Yiu Ho Woo et al.
ACTA PHARMACOLOGICA SINICA (2012)
Molecular targets in heart failure gene therapy: current controversies and translational perspectives
Victor Kairouz et al.
EVOLVING CHALLENGES IN PROMOTING CARDIOVASCULAR HEALTH (2012)
β-Adrenergic receptor stimulation causes cardiac hypertrophy via a G/Erk-dependent pathway
Marie Vidal et al.
CARDIOVASCULAR RESEARCH (2012)
High Levels of Circulating Epinehrine Trigger Apical Cardiodepression in a β2-Adrenergic Receptor/Gi-Dependent Manner A New Model of Takotsubo Cardiomyopathy
Helen Paur et al.
CIRCULATION (2012)
Role of RyR2 Phosphorylation at S2814 During Heart Failure Progression
Jonathan L. Respress et al.
CIRCULATION RESEARCH (2012)
Beyond the Cardiac Myofilament: Hypertrophic Cardiomyopathy- Associated Mutations in Genes that Encode Calcium-Handling Proteins
A. P. Landstrom et al.
CURRENT MOLECULAR MEDICINE (2012)
Prospects for gene transfer for clinical heart failure
T. Tang et al.
GENE THERAPY (2012)
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials
Catherine L. Tacon et al.
INTENSIVE CARE MEDICINE (2012)
Raf Kinase Inhibitor Protein (RKIP) Dimer Formation Controls Its Target Switch from Raf1 to G Protein-coupled Receptor Kinase (GRK) 2
Katharina Deiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Myocardial infarction in mice alters sarcomeric function via post-translational protein modification
Benjamin S. Avner et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
The Inotropic Peptide βARKct Improves βAR Responsiveness in Normal and Failing Cardiomyocytes Through Gβγ-Mediated L-Type Calcium Current Disinhibition
Mirko Voelkers et al.
CIRCULATION RESEARCH (2011)
A Critical Function for Ser-282 in Cardiac Myosin Binding Protein-C Phosphorylation and Cardiac Function
Sakthivel Sadayappan et al.
CIRCULATION RESEARCH (2011)
A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity
Hui Cheng et al.
CIRCULATION RESEARCH (2011)
Inherited Dysfunction of Sarcoplasmic Reticulum Ca2+ Handling and Arrhythmogenesis
Silvia G. Priori et al.
CIRCULATION RESEARCH (2011)
β2 AR Agonists in Treatment of Chronic Heart Failure: Long Path to Translation
Mark I. Talan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo
Jop H. van Berlo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model
Sven T. Pleger et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Ca2+ Cycling and New Therapeutic Approaches for Heart Failure
Anne-Marie Lompre et al.
CIRCULATION (2010)
Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?
Thomas Eschenhagen
JOURNAL OF CLINICAL INVESTIGATION (2010)
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
Sabine Huke et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology
Melanie Metrich et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation
Viacheslav O. Nikolaev et al.
SCIENCE (2010)
Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca2+-ATPase Inhibition
Joachim P. Schmitt et al.
CIRCULATION (2009)
α1-Adrenergic Receptor Subtypes in Nonfailing and Failing Human Myocardium
Brian C. Jensen et al.
CIRCULATION-HEART FAILURE (2009)
Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart
Stephan E. Lehnart et al.
HEART FAILURE REVIEWS (2009)
Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling
Kristina Lorenz et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Raf Kinase Inhibitory Protein Function Is Regulated via a Flexible Pocket and Novel Phosphorylation-Dependent Mechanism
Alexey E. Granovsky et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes
U. Siedlecka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy
Ali El-Armouche et al.
CARDIOVASCULAR RESEARCH (2008)
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor
Alexey E. Granovsky et al.
CELL RESEARCH (2008)
Epac mediates β-adrenergic receptor-induced cardiomyocyte hypertrophy
Melanie Metrich et al.
CIRCULATION RESEARCH (2008)
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice
Farah Sheikh et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cardioprotective and survival benefits of long-term combined therapy with β2 adrenoreceptor (AR) agonist and β1 AR blocker in dilated cardiomyopathy postmyocardial infarction
Ismayil Ahmet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
t-tubules and sarcoplasmic in cardiac ventricular reticulum function myocytes
Clive Orchard et al.
CARDIOVASCULAR RESEARCH (2008)
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo
Nicole H. Purcell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart
Lars S. Maier et al.
CARDIOVASCULAR RESEARCH (2007)
Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy
Panayota Flevari et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension
Martina Krueger et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2006)
β-Arrestin-recruited phosphodiesterase-4 desensitizes the AKAP79/PKA-mediated switching of β2-adrenoceptor signalling to activation of ERK
MD Houslay et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein
N Trakul et al.
CELL RESEARCH (2005)
Protecting the myocardium:: A role for the β2 adrenergic receptor in the heart
AJ Patterson et al.
CRITICAL CARE MEDICINE (2004)
Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload
IS Harris et al.
CIRCULATION (2004)
Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction
J van der Velden et al.
CIRCULATION RESEARCH (2004)
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2
K Lorenz et al.
NATURE (2003)
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein
KC Corbit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
JP Schmitt et al.
SCIENCE (2003)
Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function
MH Gao et al.
CARDIOVASCULAR RESEARCH (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Calcium cycling in congestive heart failure
G Hasenfuss et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes
Y Shizukuda et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Seven-transmembrane-spanning receptors and heart function
HA Rockman et al.
NATURE (2002)
Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κ13 activation
KC Yeung et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Inotropic therapy for heart failure: An evidence-based approach
GM Felker et al.
AMERICAN HEART JOURNAL (2001)
The enhanced contractility of the phospholamban-deficient mouse heart persists with aging
JP Slack et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors
U Hengst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′-kinase
A Chesley et al.
CIRCULATION RESEARCH (2000)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Share Paper
